The Association between Antigens of Human Malignant-Melanoma Cells and Mycobacterium bovis (BCG)

  • Percy Minden
  • Peter J. Kelleher
  • Linda K. Woods


Antigenic components shared between Mycobacterium bovis (BCG) and certain experimental and human tumors have been demonstrated by a variety of methods (Borsos and Rapp, 1973; Minden et al., 1974; Bucana and Hanna, 1974; Minden et al., 1976a; McCoy et al., 1978; Lewis et al., 1976; Holan et al., 1979). There are also data suggesting that other microorganisms have determinants in common with some tumors (Minden et al., 1976b; Minden, 1976; James et al., 1976; Kwapinski et al., 1978). With respect to human tumors, there is evidence that antigens from human malignant melanoma (Bucana and Hanna, 1974; Minden et al., 1976a) and acute myeloid leukemia (Minden et al., 1976b) are shared with or are similar to antigens in BCG.


Acute Myeloid Leukemia Melanoma Cell Melanoma Patient Human Malignant Melanoma Cell Line Mycobacterium Bovis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Baldwin, R. W., and Pimm, M. V., 1978, BCG in tumor immunotherapy Ado. Cancer Res. 28: 91.CrossRefGoogle Scholar
  2. Bardana, E. J., McClatchy, J. K., Farr, R. S., and Minden, P., 1973, Universal occurrence of antibodies to tubercle bacilli in sera from non-tuberculous and tuberculous individuals, Clin. Exp. Immunol. 13: 65.PubMedGoogle Scholar
  3. Bast, R. C., Bast, B. S., and Rapp, H. J., 1976, Critical review of previously reported animal studies of tumor immunotherapy with nonspecific immunostimulants, Ann. N. Y., Acad. Sc,. 277: 60.CrossRefGoogle Scholar
  4. Bias, W. B., Santos, G. W., Burke, P. J., Mullins, G. M., and Humphrey, R. L., 1972, Cytotoxic antibody in normal human serums reactive with tumor cells from acute lymphocytic leukemia, Science 178: 304.PubMedCrossRefGoogle Scholar
  5. Borsos, T., And Rapp, H. J., 1973, Antigenic relationship between Mycobacterium boots (BCG) and a guinea pig hepatoma, J. Natl. Cancer Inst. 51: 1085.PubMedGoogle Scholar
  6. Brüggen, J., Sorg, C., and Macher, E., 1978, Membrane associated antigens of human malignant melanoma. V. Serological typing of cell lines using antisera from nonhuman primates, Cancer Immunol. Immunother. 5: 53.CrossRefGoogle Scholar
  7. Brunda, M. J., and Minden, P., 1977, Antibodies to bacterial and tumor derived antigens in sera from normal guinea pigs, J. Immunol. 119: 1374.PubMedGoogle Scholar
  8. Brunda, M. J., Mathews, H. L., Ferguson, H. R., McClatchy, J. K., and Minden, P., 1980, Immunotherapy of the guinea pig line-10 hepatocarcinoma with a variety of non-viable bacteria, Cancer Res. 40: 3211.PubMedGoogle Scholar
  9. Bucana, C., and Hanna, M. G., Jr., 1974, Immunoelectronmicroscopic analysis of surface antigens common to Mycobacterium bovis (BCG) and tumor cells, J. Natl. Cancer Inst. 53: 1313.PubMedGoogle Scholar
  10. Chase, R. M., Jr., and Rapaport, F. T., 1965, The bacterial induction of homograft sensitivity. I. Effects of sensitization with group A streptococci, J. Exp. Med. 122: 721.PubMedCrossRefGoogle Scholar
  11. Clark, E. A., Russell, P. H., Egghart, M., and Horton, M. A., 1979, Characteristics and genetic control of NK-cell-mediated cytotoxicity activated by naturally acquired infection in the mouse, Int. J. Cancer. 24: 688.PubMedCrossRefGoogle Scholar
  12. Detrick-Hooks, B., Smith, H. G., Bast, R. C., Jr., Dunkel, V. C., and Borsos, T., 1976, Naturally soluble tumor antigens from guinea pig hepatomas: Isolation and partial characterization, J. Immunol. 116: 1324.PubMedGoogle Scholar
  13. Ferguson, H. R., McClatchy, J. K., Sharpton, T. R., and Minden, P., 1978, Immunological method to differentiate between antigens of tubercle bacilli, other mycobacterial species, and non-acid fast bacteria, Infect. Immunity 22: 101.Google Scholar
  14. Goebel, W. F., Shedlovsky, T., Lavin, G. I., and Adams, M. H., 1943, Heterophile antigen of pneumococcus, J. Biol. Chem. 148: 1.Google Scholar
  15. Gupta, R. K., Irie, R. F., Chee, D. O., Kern, D. H., and Morton, D. L., 1979, Demonstration of two distinct antigens in spent tissue culture medium of a human malignant melanoma cell line, J. Natl. Cancer Inst. 63: 347.PubMedGoogle Scholar
  16. Hellström, I., Hellström, K. E., Pierce, G. E., and Yang, J. P. S., 1968, Cellular and humoral immunity to different types of human neoplasms, Nature (London) 220: 1352.CrossRefGoogle Scholar
  17. Herberman, R. B., and Aoki, T., 1972, Immune and natural antibodies to syngeneic murine plasma cell tumors, J. Exp. Med. 131: 94.CrossRefGoogle Scholar
  18. Herberman, R. B., and Holden, H. T., 1979, Natural killer cells as antitumor effector cells, J. Natl. Cancer Inst. 62: 441.PubMedGoogle Scholar
  19. Herberman, R. B., Nunn, M. E., and Lavrin, D. H., 1975, Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. I. Distribution of reactivity and specificity, Int. J. Cancer 16: 216.PubMedCrossRefGoogle Scholar
  20. Hersh, E. M., Gutterman, J. U., Mavligit, G. M., Granatek, C. H., Rossen, R. D., Rios, A., Goldstein, A. L., Patt, Y. Z., Rivera, E., Richman, S. P., Bottino, J. C., Farquhar, D., Morris, D., and Ezaki, K., 1978, Clinical rationale for immunotherapy and its role in cancer treatment, in Immunotherapy of Human Cancer, p. 83, Raven Press, New York.Google Scholar
  21. Holan, V., Chutna, J., and Harsek, M., 1979, Cross-reactivity between bacillus Calmette-Guérin and Rous virus-induced sarcoma detected in rats by tube leukocyte adherence inhibition assay, Cancer Res. 39: 593.PubMedGoogle Scholar
  22. James, K., Willmott, N., Milne, I., and McBride, W. H., 1976, Antitumor antibodies and immunoglobulin class and subclass levels in Corynebacterium parvum-treated mice, J. Natl. Cancer Inst. 56: 1035.PubMedGoogle Scholar
  23. Kaplan, M. H., and Suchy, M. L., 1964, Immunologic relation of streptococcal and tissue antigens. II. Cross-reactions of antisera to mammalian heart tissue with a cell wall constituent of certain strains of group A streptococci, J. Exp. Med. 119: 643.PubMedCrossRefGoogle Scholar
  24. Kaplan, M. H., and Svec, K. H., 1964, Immunologic relation of streptococcal and tissue antigens. III. Presence in human sera of streptococcal antibody cross-reactive with heart tissue: Association with streptococcal infection, rheumatic fever and glomerulonephritis, J. Exp. Med. 119: 651.PubMedCrossRefGoogle Scholar
  25. Kwapinski, G., Oliver, H., Kwapinski, E., and Stein, M., 1978, Microbial-like antigens in human leukemia, Onocology 35: 263.CrossRefGoogle Scholar
  26. Lewis, M. G., Jerry, L. M., Rowden, G., Phillips, T. A., Shibatan, H., and Capele, A., 1976, Some effects of oral administration of BCG on immune responses in cancer patients, in BCG in Cancer Immunotherapy ( G. Lamoureux, V. Portelance, and R. Turcotte, eds.), pp. 339–358, Grune and Stratton, New York.Google Scholar
  27. Liao, S. K., Kwong, P. C., Thompson, J. C., and Dent, P. B., 1979, Spectrum of melanoma antigens on cultured human malignant melanoma cells as detected by monkey antibodies, Cancer Res. 39: 183.PubMedGoogle Scholar
  28. Mathe, G., Florentin, I., Bruly-Rossel, M., Kiger, N., and Olsson, L., 1979, Systemic immunotherapy of cancer minimal residual disease: Clinical status and new experimental data approaches, in Adjuvant Therapy of Cancer II ( S. E. Jones and S. E. Salmon, eds.), p. 87, Grune and Stratton, New York.Google Scholar
  29. McCoy, J. L., Jerome, L. F., Dean, J. H., Perlin, E., Oldham, R. K., Char, D. H., Cohen, M. H., Felix, E. L., and Herberman, R. B., 1975, Inhibition of leukocyte migration by tumor-associated antigens in soluble extracts of human malignant melanoma, J. Natl. Cancer Inst. 55: 19.PubMedGoogle Scholar
  30. McCoy, J. L., Bradhorst, J., and Hanna, M. C., Jr., 1978, Leukocyte migration inhibition of tumor antigen and purified protein derivative reactivity in guinea pigs sensitized to line-10 hepatocarcinoma and BCG, J. Natl. Cancer Inst. 60: 693.PubMedGoogle Scholar
  31. Minden, P., 1976, Shared antigens between animal and human tumors and microorganisms, in: BCG in Cancer Immunotherapy ( G. Lamoureux, V. Portelance, and R. Turcotte, eds.), pp. 73–81, Grune and Stratton, New York.Google Scholar
  32. Minden, P., and Farr, R. S., 1975, The universal presence of antibodies to microorganisms in sera from normal persons (editorial), Chest 68: 749.PubMedCrossRefGoogle Scholar
  33. Minden, P., and Mathews, H. L., 1980, Suppression and immunotherapy of the guinea pig line-10 hepatocar-cinoma mediated by heat-killed disrupted Mycobacterium bovis (BCG). Cancer Res. 40: 3214.PubMedGoogle Scholar
  34. Minden, P., McClatchy, J. K., Cooper, R., Bardana, E. J., Jr., and Farr, R. S., 1972, Shared antigens between Mycobacterium bovis (BCG) and other bacterial species, Science 176: 57.PubMedCrossRefGoogle Scholar
  35. Minden, P., McClatchy, J. K., Wainberg, M., and Weiss, D. W., 1974, Shared antigens between Mycobacterium bovis (BCG) and neoplastic cells, J. Natl. Cancer Inst. 53: 1325.PubMedGoogle Scholar
  36. Minden, P., Sharpton, T. R., and McClatchy, J. K., 1976a, Shared antigens between human malignant melanoma cells and Mycobacterium bovis (BCG), J. Immunol. 116: 1407.PubMedGoogle Scholar
  37. Minden, P., Gutterman, J. U., Sharpton, T. R., and McClatchy, J. K., 1976b, Antigenic relationships between human acute myeloid leukemia cells and Mycobacterium bovis (BCG), in Proceedings of the XIIth Joint Meeting: U.S.-Japan Cooperative Medical Science Program, Tokyo, p. 429.Google Scholar
  38. Minden, P., Sharpton, T. R., and McClatchy, J. K., 1976c, Shared antigens between bacteria and guinea pig line-10 hepatocarcinoma cells, Cancer Res. 36: 1680.PubMedGoogle Scholar
  39. Minden, P., Gutterman, J. U., Hersh, E. M., Jarrett, C., and McClatchy, J. K., 1976d, Antibodies to melanoma cell and BCG antigens in sera from tumour-free individuals and from melanoma patients, Nature (London) 263: 774.CrossRefGoogle Scholar
  40. Minden, P., Mathews, H. L., and Kelleher, P. J., 1980, Suppression of the line-10 guinea pig hepatocarcinoma by antigens related to both Mycobacterium bovis (BCG) and the tumor, J. Immunol. 125:2685Google Scholar
  41. Minden, P., Mathews, H. L., and Kelleher, P. J., 1980, Suppression of the line-10 guinea pig hepatocarcinoma by antigens related to both Mycobacterium bovis (BCG) and the tumor, J. Immunol. 125:2685PubMedGoogle Scholar
  42. Muschel, L. H., and Osawa, E., 1959, Human blood group substance B and Escherichia coli 086, Proc. Soc. Exp. Biol. Med. 101: 614.PubMedGoogle Scholar
  43. Nauts, H. C., Swift, W. E., and Coley, B. L., 1946, Treatment of malignant tumors by bacterial toxins as developed by the late William Coley, M.D., reviewed in the light of modern research, Cancer Res. 6: 205.PubMedGoogle Scholar
  44. Old, L. J., Benacerraf, B., Clarke, D. A., Carswell, E. A., and Stockert, E., 1961, The role of the reticuloen-dothelial system in the host reaction to neoplasia, Cancer Res. 21: 1281.PubMedGoogle Scholar
  45. Quinn, L. A., Woods, L. K., Merrick, S. B., Arabasz, N. M., and Moore, G. E., 1977, Cytogenetic analysis of twelve human malignant melanoma cell lines, J. Natl. Cancer Inst. 59: 301.Google Scholar
  46. Raffel, S., 1961, Tuberculosis in Immunity, 2nd ed., p. 412, Appleton-Century-Crofts, New York.Google Scholar
  47. Rapaport, F. T., 1972, The biological significance of cross-reactions between histocompatibility antigens and antigens of bacterial and/or heterologous mammalian origin in: Transplantation Antigens (B. E. Kahan and R. A. Reisfeld, eds.), pp. 182–209, Academic Press, New York.Google Scholar
  48. Rapaport, F. T., and Chase, R. M., Jr., 1964, Homograft sensitivity induction by group A streptococci, Science 145: 407.PubMedCrossRefGoogle Scholar
  49. Rapp, H. J., 1973, A guinea pig model for tumor immunology, Isr. J. Med. Sci. 9: 366.PubMedGoogle Scholar
  50. Rapp, H. J., 1976, Immunotherapy of experimental cancer as a guide to the treatment of human cancer, Ann. N. Y. Acad. Sci. 276: 550.PubMedCrossRefGoogle Scholar
  51. Ribi, E., Milner, K. C., Granger, D. L., Kelly, M. T., Yamamoto, K., Brehmer, W., Parker, R., Smith, R. F., and Strain, S. M., 1976, Immunotherapy with nonviable microbial components, Ann. N. Y. Acad. Sci. 277: 228.PubMedCrossRefGoogle Scholar
  52. Rowley, D. A., Fitch, F. W., Stuart, F. P., Köhler, H., and Cosenza, H., 1973, Specific suppression of immune responses, Science 181: 1133.PubMedCrossRefGoogle Scholar
  53. Ruckdeschel, J. C., Codish, S. D., Stranahan, A., and McKneally, M. F., 1972, Post operative empyema improves survival in lung cancer. Documentation and analysis of a natural experiment, N. Engl. J. Med. 287: 1013.PubMedCrossRefGoogle Scholar
  54. Sharma, B., and Terasaki, P. I., 1974, In vitro immunization to cultured human tumor cells, Cancer Res. 34: 115.PubMedGoogle Scholar
  55. Sharma, B., Tubergen, D. G., Minden, P., and Brunda, M. J., 1977, In vitro immunisation against human tumour cells with bacterial extracts, Nature (London) 267: 845.CrossRefGoogle Scholar
  56. Sharma, B., Brunda, M. J., and Minden, P., 1979, Generation of cytotoxic lymphocytes against human tumor cells in vitro by various soluble microbial extracts, J. Natl. Cancer Inst. 63: 341.PubMedGoogle Scholar
  57. Shiku, H., Takahashi, T., Oettgen, H. F., and Old, L. J., 1976, Cell surface antigens of human malignant melanoma. II. Serological typing with immune adherence assays and definition of two new surface antigens, J. Exp. Med. 144: 873.PubMedCrossRefGoogle Scholar
  58. Springer, G. F., 1967, The relation of microbes to blood group-active substances, in Cross-Reacting Antigens and Neo-Antigens ( J. Trenton, ed.), pp. 29–47, Williams and Wilkins, Baltimore.Google Scholar
  59. Weiss, D. W., 1972, Nonspecific stimulation and modulation of the immune response and of states of resistance by the methanol-extraction residue fraction of tubercle bacilli, Natl. Cancer Inst. Monogr. 35: 157.PubMedGoogle Scholar
  60. Zbar, B., Ribi, E., Kelly, M., Granger, D., Evans, C., and Rapp, H. J., 1976, Immunologic approaches to the treatment of human cancer based on a guinea pig model, Cancer Immunol. Immunother. 1: 127CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1982

Authors and Affiliations

  • Percy Minden
    • 1
  • Peter J. Kelleher
    • 1
  • Linda K. Woods
    • 2
  1. 1.Department of MedicineNational Jewish Hospital and Research CenterDenverUSA
  2. 2.Surgical Oncology LaboratoryDenver General HospitalDenverUSA

Personalised recommendations